Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

NCT: NCT05214365 · RECRUITING

NCT IDNCT05214365
StatusRECRUITING
Start Date2022-02-01
Completion2026-09-01

Brief Summary

The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.

Frequently Asked Questions

What is Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy?

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy is a clinical trial registered under NCT05214365. Current status: RECRUITING.

What is the status of NCT05214365?

The current status of NCT05214365 (Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy) is: RECRUITING.

When did Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy start?

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy started on 2022-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑